| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |